Alembic Pharmaceuticals reported a 23% decline in net profit for the third quarter, amounting to ₹138.4 crore, compared to ₹180.4 crore in the same period last year. Revenue increased by 3.8% to ₹1,692.7 crore from ₹1,630.6 crore year-on-year. The company's EBITDA fell by 2.1% to ₹260 crore, with a margin of 15.4%, down from 16.3% year-on-year. Meanwhile, Castrol India announced a 30.8% rise in net profit for the fourth quarter, reaching ₹271 crore, as revenue grew by 5.1% to ₹1,354 crore. The company's EBITDA surged by 31.4% to ₹376 crore, resulting in an EBITDA margin increase to 27.8% from 22.2%. Additionally, RVNL secured a letter of acceptance from East Coast Railway for a ₹404.4 crore road doubling project, which includes the construction of 27 major bridges. The company's shares rose by 4.04% to ₹416.30 following the announcement. MTNL shares experienced a surge of 20% amid positive sentiment surrounding its asset monetization plans, which are projected to generate ₹16,000 crore.